Skip to content

Prehospital Clopidogrel versus Ticagrelor in Patients going Primary Percutaneous Coronary Intervention with Large Anterior Myocardial Infarction on platelet aggregation and myocardial perfusion

Prehospital Clopidogrel versus Ticagrelor in Patients going Primary Percutaneous Coronary Intervention with Large Anterior Myocardial Infarction on platelet aggregation and myocardial perfusion

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-14005454
Enrollment
Unknown
Registered
2014-11-07
Start date
2014-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ST-Segment elevation myocardial infarction

Interventions

A:Clopidogrel 600mg
B:Ticagrelor 180mg

Sponsors

Guangzhou military hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Men or women are aged 18 to 80; 2. had a symptom duration of more than 30 minutes but less than 6 hours; 3. Electrocardiogram (ecg) of two or more adjacent lead ST segment elevation more than 0.1mV of V1-V4; 4.vAgree to accept direct PCI therapy and agreed to participate in clinical research.

Exclusion criteria

Exclusion criteria: 1. A history of myocardial infarction, CABG or Anterior descending artery stent implantation; 2. Patients were treated with thrombolytic therapy; 3. Having direct PCI contraindications; 4. Having CMR contraindications; 5. Can't stop treatment with oral anticoagulants; 6. Using CYP3A or GP IIb/IIIa Inhibitors; 7. The platelet count less than 100000/mm^3 and more than 700000/mm^3 or Hb less than 100g/L; 8. Having the following conditions: known sick sinus syndrome, second degree atrioventricular block or bradycardia causing syncopeIn the absence of a functional implantable pacemaker case, have any of the following conditions: known sick sinus syndrome, second degree atrioventricular block or bradycardia causing syncope; 9. Within serious infectious diseases;at the end-stage of organic function failureor with advanced cancers and the life expectancy is less than a year; 10. Recent (less than 3 months) had received surgical treatment of patients with traumatic surgery; 11. Patients recently with ischemic stroke, TIA and the history of hemorrhagic stroke (less than 6 months); 12. Participating other clinical trails; 13. Not The proximal left anterior descending artery committed; 14. Going CABG within 30 days; 15. Requiring dialysis or IABP assistant.

Design outcomes

Primary

MeasureTime frame
IPA;TMPG;MSI;

Secondary

MeasureTime frame
TIMI;MACE;

Contacts

Public ContactDingcheng Xiang
1029181895@qq.com+86 13268265228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026